Clinical Trial Update: Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing varenicline to a nicotine transdermal patch for smoking cessation in patients with coronary heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Nicotine transdermal patch (nicotine patch)
• Varenicline (varenicline)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Heart Disease | Phase 4 | Status: COMPLETED